Back
Intra-Cellular Therapies Vs. Ovid Therapeutics Industry Stock Comparison
Sell
26
ITCI
Intra-Cellular Therapies
Last Price:
77.06
Seasonality Move:
-4.41%
Sell
16
OVID
Ovid Therapeutics
Last Price:
1.17
Seasonality Move:
-0.74%
Sell
26
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $76.97. The Score for ITCI is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
16
Ovid Therapeutics (OVID)
is a Sell
Is Ovid Therapeutics a Buy, Sell or Hold?
- The current Ovid Therapeutics [OVID] share price is $1.17. The Score for OVID is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- OVID is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $76.97
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing buying pressure, which is a positive indicator for future bullish movement.
OVID Stock Price Chart
What is Ovid Therapeutics's stock price today?
-
The Ovid Therapeutics share price today is $1.17
The current trend is relatively stagnant and OVID is experiencing buying pressure, which is a positive indicator for future bullish movement.
ITCI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 61.02 | Buy |
| Chaikin Money Flow: | 455173 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.18 - 75.7) | Buy |
| Bollinger Bands (100): | (68.22 - 76.74) | Buy |
OVID Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 53.54 | Buy |
| Chaikin Money Flow: | 92348 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.08 - 1.22) | Buy |
| Bollinger Bands (100): | (0.7 - 2.72) | Sell |
ITCI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.11 | Buy |
| 20-day SMA: | 74.12 | Buy |
| 50-day SMA: | 75.78 | Buy |
| 200-day SMA: | 70.5 | Buy |
| 8-day EMA: | 75.2 | Buy |
| 20-day EMA: | 74.76 | Buy |
| 50-day EMA: | 74.42 | Buy |
| 200-day EMA: | 69.87 | Buy |
OVID Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.13 | Buy |
| 20-day SMA: | 1.15 | Buy |
| 50-day SMA: | 1.06 | Buy |
| 200-day SMA: | 2.51 | Sell |
| 8-day EMA: | 1.13 | Buy |
| 20-day EMA: | 1.12 | Buy |
| 50-day EMA: | 1.22 | Sell |
| 200-day EMA: | 2.16 | Sell |
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.23 per share, an increase this year of $0.97 per share, and an increase next year of $1.07 per share.
Ovid Therapeutics Earnings Growth & OVID Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.50 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.22 per share, and a decrease next year of $0.23 per share.
Intra-Cellular Therapies Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ovid Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||